Can we cure hepatitis B virus with novel direct-acting antivirals?

Martinez, Maria G; Villeret, François; Testoni, Barbara; Zoulim, Fabien

Martinez, Maria G; Villeret, François; Testoni, Barbara; Zoulim, Fabien.

Affiliation

Martinez MG; Cancer Research Center of Lyon (CRCL), Lyon, France.
Villeret F; INSERM, U1052, Lyon, France.
Testoni B; Cancer Research Center of Lyon (CRCL), Lyon, France.
Zoulim F; INSERM, U1052, Lyon, France.

Liver Int ; 40 Suppl 1: 27-34, 2020 02.

Article in En | MEDLINE | ID: mdl-32077597

Subject(s)

Hepatitis B, Chronic; Hepatitis B; Hepatitis C, Chronic; Antiviral Agents/pharmacology; Antiviral Agents/therapeutic use; DNA, Circular; DNA, Viral; Hepatitis B/drug therapy; Hepatitis B Surface Antigens; Hepatitis B virus/genetics; Hepatitis B, Chronic/drug therapy; Hepatitis C, Chronic/drug therapy; Humans; Quality of Life; Virus Replication

Key words

cccDNA; HBV cure; chronic hepatitis B; direct acting antiviral

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B, Chronic / Hepatitis C, Chronic / Hepatitis B Limits: Humans Language: En Journal: Liver Int Journal subject: GASTROENTEROLOGIA Year: 2020 Type: Article Affiliation country: France

Fulltext

XML

PubMed Links

Search on Google